Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
CULP | US
0.01
0.20%
Consumer Cyclical
Textile Manufacturing
30/04/2024
30/08/2024
5.02
4.99
5.11
4.97
Culp Inc. manufactures sources markets and sells mattress fabrics sewn covers and cut and sewn kits for use in mattresses foundations and other bedding products in the United States North America the Far East Asia and internationally. It operates in two segments Mattress Fabrics and Upholstery Fabrics. The Mattress Fabrics segment offers woven jacquard knitted and converted fabrics for use in the production of bedding products including mattresses box springs foundations and top of bed components. The Upholstery Fabrics segment provides jacquard woven fabrics velvets micro denier suedes woven dobbies knitted fabrics piece-dyed woven products and polyurethane fabrics for use in the production of residential and commercial upholstered furniture such as sofas recliners chairs loveseats sectionals and sofa-beds as well as office seating and window treatment products; and installation services for customers in the hospitality and commercial industries. Culp Inc. was founded in 1972 and is headquartered in High Point North Carolina.
View LessPositive Momentum
Strength based on increasing price with high volume
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
27.4%1 month
35.7%3 months
32.5%6 months
31.1%-
10.57
0.82
0.06
0.03
-57.36
0.25
0.59
-3.76M
62.60M
62.60M
-
-8.24
-63.40
-19.40
-16.73
1.54
0.26
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.41
Range1M
0.63
Range3M
1.15
Rel. volume
1.15
Price X volume
67.74K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
No data |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Eagle Pharmaceuticals Inc | EGRX | Drug Manufacturers-Specialty & Generic | 5.14 | 66.61M | -1.91% | 6.05 | 27.85% |
Sonoma Pharmaceuticals Inc | SNOA | Drug Manufacturers-Specialty & Generic | 3.3 | 63.19M | 3.55% | n/a | 8.44% |
Orexo AB (publ) | ORXOY | Drug Manufacturers-Specialty & Generic | 1.51 | 55.31M | 1.48% | n/a | 0.00% |
SCYNEXIS Inc | SCYX | Drug Manufacturers-Specialty & Generic | 1.46 | 55.27M | 0.00% | n/a | 25.73% |
Qilian International Holding Group Limited | QLI | Drug Manufacturers-Specialty & Generic | 6.97 | 53.06M | 4.81% | n/a | 1.35% |
DURECT Corporation | DRRX | Drug Manufacturers-Specialty & Generic | 1.48 | 45.94M | 3.50% | n/a | 318.92% |
BGXX | BGXX | Drug Manufacturers-Specialty & Generic | 0.2271 | 43.41M | -3.28% | n/a | 0.00% |
Provectus Biopharmaceuticals Inc | PVCT | Drug Manufacturers-Specialty & Generic | 0.09 | 38.93M | -5.26% | n/a | 0.00% |
India Globalization Capital Inc | IGC | Drug Manufacturers-Specialty & Generic | 0.3596 | 27.20M | 1.38% | n/a | 4.33% |
MEI Pharma Inc | MEIP | Drug Manufacturers-Specialty & Generic | 3.1 | 20.65M | -4.91% | 0.79 | 22.86% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -57.36 | - | - |
Ent. to Revenue | 0.25 | - | - |
PE Ratio | - | - | - |
Price to Book | 0.82 | - | - |
Dividend Yield | - | - | - |
Std. Deviation (3M) | 32.49 | - | - |
Debt to Equity | 0.06 | - | - |
Debt to Assets | 0.03 | - | - |
Market Cap | 62.60M | - | - |